Harmony Biosciences

HRMY • NASDAQ •
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $154,615 $168,412 $160,268 $134,216
Gross Profit 121,170 125,260 127,972 109,208
EBITDA 58,157 61,244 70,610 46,871
EBIT 52,033 55,119 64,504 46,902
Net Income 38,334 26,607 38,461 34,300
Net Change In Cash 154,615 168,412 160,268 134,216
Cost of Revenue 28,953
Free Cash Flow 31,136 76,558 63,100 36,858
Cash 332,981 311,660 324,603 317,415
Basic Shares 57,597 58,853 60,681 60,743

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $582,022 $437,855 $305,440 $159,742
Gross Profit 460,786 354,374 249,922 132,004
EBITDA 231,278 120,355 87,544 13,915
EBIT 206,919 120,186 68,704 3,678
Net Income 128,853 181,468 34,597 -51,856
Net Change In Cash 582,022 437,855 305,440 159,742
Cost of Revenue 9,475 5,678 204,174
Free Cash Flow 219,075 104,294 -1,741 -4,987
Cash 311,660 243,784 234,309 228,631
Basic Shares 60,372 61,097 59,205 56,890

Earnings Calls

Quarter EPS
2024-03-31 $0.67
2023-12-31 $0.45
2023-09-30 $0.75
2023-06-30 $0.56